MIRAGEN THERAPEUTICS, INC. License Agreements
14 Contracts & Agreements
- Amended and Restated License Agreement by and between Registrant and Paragon Therapeutics, Inc. dated as of September 20, 2024 (Filed With SEC on November 12, 2024)
- Technology License Agreement, by and between the Registrant and Xencor, Inc., dated as of December 16, 2020 (Filed With SEC on March 26, 2021)
- License Agreement, by and between the Company and ImmunoGen, dated as of October 12, 2020 (Filed With SEC on December 9, 2020)
- Amendment No. 1 to Amended and Restated License Agreement, effective as of August 8, 2019, by and between Registrant and Roche Innovation Center Copenhagen A/S (Filed With SEC on November 8, 2019)
- THE BRIGHAM ANDWOMENS HOSPITAL, INC. EXCLUSIVE PATENT LICENSE AGREEMENT BWH Agreement No: A223064 BWH Case No: BWH 21174 (Filed With SEC on December 2, 2016)
- AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on December 2, 2016)
- EXCLUSIVE PATENT LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF TEXAS SYSTEM AND MIRAGEN THERAPEUTICS, INC. TABLE OF CONTENTS (Filed With SEC on December 2, 2016)
- EXCLUSIVE PATENT LICENSE AGREEMENT BETWEEN THE UNIVERSITYOF TEXAS SYSTEM AND MIRAGEN THERAPEUTICS, INC. TABLE OF CONTENTS (Filed With SEC on December 2, 2016)
- LICENSE AGREEMENT (Filed With SEC on April 9, 2014)
- AMENDMENT #4 to the LICENSE AGREEMENT (Filed With SEC on March 19, 2014)
- AMENDMENT #3 to the LICENSE AGREEMENT (Filed With SEC on March 19, 2014)
- AMENDMENT #2 to the LICENSE AGREEMENT (Filed With SEC on March 19, 2014)
- FIRSTAMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 19, 2014)
- LICENSE AGREEMENT (Filed With SEC on March 19, 2014)
